[PDF] unipd.it

[PDF][PDF] Efficacy and safety of off-label use of rituximab in refractory lupus: data from the Italian Multicentre Registry

L Iaccarino, E Bartoloni, L Carli… - Clinical and …, 2015 - research.unipd.it
Efficacy and safety of off-label use of rituximab in refractory lupus: data from the Italian Multicentre
Registry Page 1 Clinical and Experimental Rheumatology 2015; 33: 449-456. Efficacy and …
被引用次数：139 相关文章 HTML 版

Efficacy and safety of off-label use of rituximab in refractory lupus: data from the Italian Multicentre Registry

L Iaccarino, E Bartoloni, L Carli, F Ceccarelli… - CLINICAL AND …, 2015 - iris.uniroma1.it
OBJECTIVES: To evaluate the efficacy and safety of rituximab (RTX) in patients with
systemic lupus erythematosus (SLE) refractory to standard therapy in the clinical practice …

Efficacy and safety of off-label use of rituximab in refractory lupus: data from the Italian Multicentre Registry

L Iaccarino, E Bartoloni, L Carli… - Clinical and …, 2015 - pubmed.ncbi.nlm.nih.gov
Objectives To evaluate the efficacy and safety of rituximab (RTX) in patients with systemic
lupus erythematosus (SLE) refractory to standard therapy in the clinical practice setting …
[PDF] unipd.it

[PDF][PDF] Efficacy and safety of off-label use of rituximab in refractory lupus: data from the Italian Multicentre Registry

L Iaccarino, E Bartoloni, L Carli… - Clinical and …, 2015 - research.unipd.it
Efficacy and safety of off-label use of rituximab in refractory lupus: data from the Italian Multicentre
Registry Page 1 Clinical and Experimental Rheumatology 2015; 33: 449-456. Efficacy and …

Efficacy and safety of off-label use of rituximab in refractory lupus: data from the Italian Multicentre Registry

L Iaccarino, E Bartoloni, L Carli, F Ceccarelli… - CLINICAL AND …, 2015 - arpi.unipi.it
To evaluate the efficacy and safety of rituximab (RTX) in patients with systemic lupus
erythematosus (SLE) refractory to standard therapy in the clinical practice setting …

[引用][C] Efficacy and safety of off-label use of rituximab in refractory lupus: data from the Italian Multicentre Registry

L Iaccarino, E Bartoloni, L Carli, F Ceccarelli… - CLINICAL AND …, 2015 - iris.unito.it
Efficacy and safety of off-label use of rituximab in refractory lupus: data from the Italian
Multicentre Registry IRIS IRIS Home Sfoglia Macrotipologie & tipologie Autore Titolo Riviste …

Efficacy and safety of off-label use of rituximab in refractory lupus: data from the Italian Multicentre Registry

L Iaccarino, E Bartoloni, L Carli, F Ceccarelli… - CLINICAL AND …, 2015 - iris.unibs.it
OBJECTIVES: To evaluate the efficacy and safety of rituximab (RTX) in patients with
systemic lupus erythematosus (SLE) refractory to standard therapy in the clinical practice …

Efficacy and safety of off-label use of rituximab in refractory lupus: data from the Italian Multicentre Registry.

L Iaccarino, E Bartoloni, L Carli… - Clinical and …, 2015 - europepmc.org
Objectives To evaluate the efficacy and safety of rituximab (RTX) in patients with systemic
lupus erythematosus (SLE) refractory to standard therapy in the clinical practice setting …
[PDF] academia.edu

[PDF][PDF] Efficacy and safety of off-label use of rituximab in refractory lupus: data from the Italian Multicentre Registry

L Iaccarino, E Bartoloni, L Carli, F Ceccarelli… - Clinical and …, 2015 - academia.edu
Efficacy and safety of off-label use of rituximab in refractory lupus: data from the Italian Multicentre
Registry Page 1 Clinical and Experimental Rheumatology 2015; 33: 449-456. Efficacy and …

Efficacy and safety of off-label use of rituximab in refractory lupus: data from the Italian Multicentre Registry

L Iaccarino, E Bartoloni, L Carli… - CLINICAL AND …, 2015 - publicatt.unicatt.it
Efficacy and safety of off-label use of rituximab in refractory lupus: data from the Italian
Multicentre Registry IRIS IRIS Home Sfoglia Macrotipologie & tipologie Autore Titolo Riviste …